Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dydrogesterone vs. Vaginal Progesterone for Luteal Phase Support in FET
NCT04124913Phase 4Unknown
- Start
- Jan 2019
- Primary completion
- Oct 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dydrogesterone in infertility (2 arms). Primary endpoint: Ongoing pregnancy rate at 12 weeks. Status: unknown.
02
Drugs
dydrogesterone
03
Conditions
infertility
Beyond the preview
Go deeper on NCT04124913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04124913.